Applied Biosciences Corp. (OTCPK: APPB)
Health Care · Pharmaceuticals · US
$0.00
— today · 0.0% 1Y
Applied Biosciences Corp. (OTCPK: APPB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.14K and employs 25 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Applied Biosciences Corp. across four factors: quality 19/100, value 45/100. Its strongest factor is value.
APPB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.14K
- Revenue (TTM)
- $859.86K
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 80.30
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.40M
- Employees
- 25
- Next earnings
- —
About Applied Biosciences Corp.
Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.
- ISIN
- US03815L1026
- Founded
- 2014
- Listed since
- Feb 9, 2016
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.